This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hou, W.-S. Articles by Brömme, D. Search for Related Content PubMed PubMed Citation Articles by Hou, W.-S. Articles by Brömme, D.

(American Journal of Pathology. 2001;159:2167-2177.)
© 2001 American Society for Investigative Pathology

Regular Article

Cathepsin K Is a Critical Protease in Synovial Fibroblast-Mediated Collagen Degradation

Wu-Shiun Hou^*, Zhenqiang Li^*, Ronald E. Gordon, Kyle Chan, Michael J. Klein, Roger Levy, Martin Keysser^¶, Gernot Keyszer^|| and Dieter Brömme^*

From the Departments of Human Genetics,^*
Orthopaedics,
and Pathology,
Mount Sinai School of Medicine, New York, New York; the Regionales Rheumazentrum Rostock,^¶
Rostock, Germany; the Signal Research Division,
Celgene, San Diego, California; the Department of Medicine,^||
Clinic of Internal Medicine, Martin Luther University Halle-Wittenberg, Halle, Germany

Synovial fibroblasts (SFs) play a critical role in the pathogenesis of rheumatoid arthritis (RA) and are directly involved in joint destruction. Both SF-resident matrix metalloproteases and cathepsins have been implicated in cartilage degradation although their identities and individual contributions remain unclear. The aims of this study were to investigate the expression of cathepsin K in SFs, the correlation between cathepsin K expression and disease severity, and the contribution of cathepsin K to fibroblast-mediated collagen degradation. Immunostaining of joint specimens of 21 patients revealed high expression of cathepsin K in SFs in the synovial lining and the stroma of synovial villi, and to a lesser extent in CD68-positive cells of the synovial lining. Cathepsin K-positive SFs were consistently observed at sites of cartilage and bone degradation. Expression levels of cathepsin K in the sublining and vascularized areas of inflamed synovia showed a highly significant negative correlation with results derived from the Hannover Functional Capacity Questionnaire (r = 0.78, P = 0.003; and r = 0.70, P = 0.012, respectively) as a measure of the severity of RA in individual patients. For comparison, there was no correlation between Hannover Functional Capacity Questionnaire and cathepsin S whose expression is limited to CD-68-positive macrophage-like synoviocytes. The expression of cathepsin K was also demonstrated in primary cell cultures of RA-SFs. Co-cultures of SFs on cartilage disks revealed the ability of fibroblast-like cells to phagocytose collagen fibrils whose intralysosomal hydrolysis was prevented in the presence of a potent cathepsin K inhibitor but not by an inhibitor effective against cathepsins L, B, and S. The selective and critical role of cathepsin K in articular cartilage and subchondral bone erosion was further corroborated by the finding that cathepsin K has a potent aggrecan-degrading activity and that cathepsin K-generated aggrecan cleavage products specifically potentiate the collagenolytic activity of cathepsin K toward type I and II collagens. This study demonstrates for the first time a critical role of cathepsin K in cartilage degradation by SFs in RA that is comparable to its well-known activity in osteoclasts.

This article has been cited by other articles:

				M. Chwa, S. R. Atilano, D. Hertzog, H. Zheng, J. Langberg, D. W. Kim, and M. C. Kenney Hypersensitive Response to Oxidative Stress in Keratoconus Corneal Fibroblasts Invest. Ophthalmol. Vis. Sci., October 1, 2008; 49(10): 4361 - 4369. [Abstract] [Full Text] [PDF]

				S. B. Rodan and L. T. Duong Cathepsin K - A New Molecular Target for Osteoporosis IBMS BoneKEy, January 1, 2008; 5(1): 16 - 24. [Abstract] [Full Text] [PDF]

				B. Winchester Lysosomal metabolism of glycoproteins Glycobiology, June 1, 2005; 15(6): 1R - 15R. [Abstract] [Full Text] [PDF]

				K. Hayashi, P. A. Manley, and P. Muir Cranial Cruciate Ligament Pathophysiology in Dogs With Cruciate Disease: A Review J. Am. Anim. Hosp. Assoc., September 1, 2004; 40(5): 385 - 390. [Abstract] [Full Text] [PDF]

				Y. Yasuda, Z. Li, D. Greenbaum, M. Bogyo, E. Weber, and D. Bromme Cathepsin V, a Novel and Potent Elastolytic Activity Expressed in Activated Macrophages J. Biol. Chem., August 27, 2004; 279(35): 36761 - 36770. [Abstract] [Full Text] [PDF]

				F. Buhling, C. Rocken, F. Brasch, R. Hartig, Y. Yasuda, P. Saftig, D. Bromme, and T. Welte Pivotal Role of Cathepsin K in Lung Fibrosis Am. J. Pathol., June 1, 2004; 164(6): 2203 - 2216. [Abstract] [Full Text] [PDF]

				J P Morko, M Soderstrom, A-M K Saamanen, H J Salminen, and E I Vuorio Up regulation of cathepsin K expression in articular chondrocytes in a transgenic mouse model for osteoarthritis Ann Rheum Dis, June 1, 2004; 63(6): 649 - 655. [Abstract] [Full Text]

				Z. Li, Y. Yasuda, W. Li, M. Bogyo, N. Katz, R. E. Gordon, G. B. Fields, and D. Bromme Regulation of Collagenase Activities of Human Cathepsins by Glycosaminoglycans J. Biol. Chem., February 13, 2004; 279(7): 5470 - 5479. [Abstract] [Full Text] [PDF]

				K. W. Dwyer, P. P. Provenzano, P. Muir, W. B. Valhmu, and R. Vanderby Jr. Blockade of the sympathetic nervous system degrades ligament in a rat MCL model J Appl Physiol, February 1, 2004; 96(2): 711 - 718. [Abstract] [Full Text] [PDF]

				C. A. Seemayer, S. Kuchen, P. Kuenzler, V. Rihoskova, J. Rethage, W. K. Aicher, B. A. Michel, R. E. Gay, D. Kyburz, M. Neidhart, et al. Cartilage Destruction Mediated by Synovial Fibroblasts Does Not Depend on Proliferation in Rheumatoid Arthritis Am. J. Pathol., May 1, 2003; 162(5): 1549 - 1557. [Abstract] [Full Text] [PDF]